LEXICON PHARMACEUTICALS, INC. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Lexicon Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Lexicon Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 8, 2024 was 361M shares, a 47.6% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 361M +117M +47.6% Nov 8, 2024 10-Q 2024-11-13
Q2 2024 361M +117M +47.6% Jul 30, 2024 10-Q 2024-08-02
Q1 2024 246M +57.5M +30.5% Mar 21, 2024 10-K 2024-03-25
Q3 2023 245M +55.4M +29.2% Nov 6, 2023 10-Q 2023-11-08
Q2 2023 245M +61.3M +33.4% Aug 1, 2023 10-Q 2023-08-04
Q1 2023 189M +39.1M +26.2% Mar 1, 2023 10-K 2023-03-03
Q3 2022 190M +40.7M +27.3% Nov 7, 2022 10-Q 2023-05-04
Q2 2022 184M +39.2M +27.1% Aug 3, 2022 10-Q 2022-08-03
Q1 2022 150M +5.21M +3.61% May 4, 2022 10-Q 2022-05-05
Q3 2021 149M +31.4M +26.7% Nov 1, 2021 10-Q 2021-11-09
Q2 2021 144M +37.4M +34.9% Aug 3, 2021 10-Q 2021-08-06
Q1 2021 144M +37.4M +35% May 4, 2021 10-Q 2021-05-06
Q3 2020 117M +11.2M +10.5% Oct 26, 2020 10-Q 2020-10-30
Q2 2020 107M +834K +0.79% Jul 24, 2020 10-Q 2020-07-29
Q1 2020 107M +698K +0.66% Apr 23, 2020 10-Q 2020-04-27
Q3 2019 106M +347K +0.33% Nov 4, 2019 10-Q 2019-11-07
Q2 2019 106M +393K +0.37% Jul 29, 2019 10-Q 2019-08-01
Q1 2019 106M +440K +0.42% Mar 8, 2019 10-K 2019-03-15
Q3 2018 106M +338K +0.32% Oct 29, 2018 10-Q 2018-11-01
Q2 2018 106M +297K +0.28% Jul 26, 2018 10-Q 2018-07-30
Q1 2018 106M +1.51M +1.45% Apr 30, 2018 10-Q 2018-05-03
Q3 2017 106M +1.55M +1.49% Nov 6, 2017 10-Q 2017-11-08
Q2 2017 106M +1.72M +1.65% Jul 28, 2017 10-Q 2017-08-01
Q1 2017 104M +550K +0.53% Mar 1, 2017 10-K 2017-03-06
Q3 2016 104M +414K +0.4% Nov 3, 2016 10-Q 2016-11-07
Q2 2016 104M +252K +0.24% Aug 1, 2016 10-Q 2016-08-04
Q1 2016 104M -621M -85.7% Mar 7, 2016 10-K 2016-03-11
Q3 2015 104M -411M -79.9% Nov 4, 2015 10-Q 2015-11-09
Q2 2015 104M -411M -79.9% Aug 4, 2015 10-Q 2015-08-07
Q1 2015 725M +211M +41.1% Mar 9, 2015 10-K 2015-03-12
Q3 2014 515M +1.32M +0.26% Nov 4, 2014 10-Q 2014-11-06
Q2 2014 515M +1.37M +0.27% Aug 4, 2014 10-Q 2014-08-07
Q1 2014 514M +788K +0.15% Feb 27, 2014 10-K 2014-03-07
Q3 2013 514M +1.14M +0.22% Nov 8, 2013 10-Q 2013-11-12
Q2 2013 513M +19.1M +3.87% Jul 29, 2013 10-Q 2013-08-01
Q1 2013 513M +32.4M +6.75% Mar 8, 2013 10-K 2013-03-11
Q3 2012 512M +175M +51.7% Nov 5, 2012 10-Q 2012-11-07
Q2 2012 494M +157M +46.4% Jul 31, 2012 10-Q 2012-08-02
Q1 2012 481M Mar 5, 2012 10-K 2012-03-08
Q3 2011 338M Oct 28, 2011 10-Q 2011-11-01
Q2 2011 338M Aug 4, 2011 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.